A majority of EU member states are pushing for legislation to address shortages of critical drugs and to reduce dependency on imported chemicals from China and other countries.
In a paper seen by the Financial Times, Belgium and 18 other countries — including Germany and France — have gone further than Brussels’ recent proposals to overhaul the bloc’s pharmaceuticals laws, calling for a “last-resort” mechanism to swap medicines between member states and the establishment of a list of critical drugs whose supply chains must be monitored.
The Covid-19 pandemic and Russia’s full-scale invasion of Ukraine have thrown into sharp relief both the fragility and strategic importance of pharmaceutical supply chains.
您已閱讀19%（713字），剩餘81%（2981字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。